Can circular RNAs be used as prenatal biomarkers for congenital diaphragmatic hernia?
- 14 November 2019
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (2) , 1900514
Abstract
No abstract availableFunding Information
- Manitoba Lung Association
- Institute of Human Development, Child and Youth Health
This publication has 15 references indexed in Scilit:
- Establishment of a biobank for human lung tissues of congenital diaphragmatic hernia and congenital pulmonary airway malformationJournal of Pediatric Surgery, 2019
- Prenatal microRNA miR-200b Therapy Improves Nitrofen-induced Pulmonary Hypoplasia Associated With Congenital Diaphragmatic HerniaAnnals of Surgery, 2019
- Prenatally versus postnatally diagnosed congenital diaphragmatic hernia – Side, stage, and outcomeJournal of Pediatric Surgery, 2019
- Circular RNAs (circRNAs) in Health and DiseaseGenes, 2017
- Circular RNAs in cancer: opportunities and challenges in the fieldOncogene, 2017
- Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery diseaseScientific Reports, 2017
- Circular RNAs as Promising Biomarkers: A Mini-ReviewFrontiers in Physiology, 2016
- Unique Tracheal Fluid MicroRNA Signature Predicts Response to FETO in Patients With Congenital Diaphragmatic HerniaAnnals of Surgery, 2015
- Congenital diaphragmatic herniaSeminars in Pediatric Surgery, 2010
- Timing of lung size assessment in the prediction of survival in fetuses with diaphragmatic herniaUltrasound in Obstetrics & Gynecology, 2007